20.08.2013 Views

PHTD 2012 Spring Meeting - units.sla.org

PHTD 2012 Spring Meeting - units.sla.org

PHTD 2012 Spring Meeting - units.sla.org

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>PHTD</strong> <strong>2012</strong> <strong>Spring</strong> <strong>Meeting</strong>, Baltimore MD<br />

42<br />

F1000<br />

General Biologic<br />

Information Express<br />

Faculty of 1000 is a post-publication peer review service that highlights<br />

important articles based on the opinions of global leaders in biology<br />

and medicine. F1000’s distinguished international Faculty of 10,000<br />

top researchers and clinicians select, rate, and evaluate key articles in<br />

these fields, and provide a short evaluation explaining why the article is important. More than<br />

115,000 evaluations are published on F1000.com covering essential and interesting research from<br />

3,500 journals. The service also includes F1000 Posters, an open access repository for posters and<br />

slide presentations across biology and medicine, and F1000 Reports, peer-reviewed reports on<br />

emerging themes in the life sciences.The service also now includes F1000 Posters, an open access<br />

repository of biomedical conference posters, reviewed and evaluated by the Faculty. The open<br />

access F1000 Reports journals provide unique, peer-reviewed perspectives from the world’s top<br />

scientists on emerging themes in biology and medicine. The Scientist - F1000’s magazine of the<br />

life sciences, provides compelling coverage of the latest developments in research, technology,<br />

business and careers.<br />

GBI is a leading information provider covering China’s pharmaceutical,<br />

biotechnology, and healthcare industries. GBI’s flagship data<br />

system, SOURCE, and industry newsletter, China Pharmaceutical &<br />

Biotechnology Review, have set a new standard for tracking and acting<br />

in China’s dynamic landscape. GBI provides the data, insights, and market transparency<br />

pharmaceutical and biotechnology companies need to capitalize on the opportunities available<br />

in China.<br />

GBI’s SOURCE data system provides unprecedented access to a wealth of critical news, data, and<br />

analytics on virtually every aspect of China’s pharmaceutical industry and healthcare market.<br />

Whether monitoring pipeline and deals activity, newly registered drugs and emerging local<br />

players, pricing and reimbursement, patents and trademarks, or hospital and physician profiles,<br />

SOURCE is essential. SOURCE provides customizable alerts and drug tracking capabilities and<br />

enables fast and easy retrieval of the latest industry developments and comparative market<br />

data. SOURCE’s powerful mapping, benchmarking and analytical tools help users make better<br />

forecasts and informed strategic decisions.<br />

This spring, GBI will be launching three new pharma intelligence products—INTELEX, METRIX,<br />

and SOURCE BRAZIL.<br />

To learn more or see a product demo, please stop by the GBI table, call our US office at (703) 938-<br />

0279, or visit our website: www.gbipharma.com.<br />

Founded in 1985, Information Express (IE) has become the leader in finding<br />

innovative, customized solutions for institutional document delivery needs. A<br />

full service company specializing in the fast, accurate and competitively priced<br />

delivery of published articles for all industries, IE is the document provider<br />

of choice for a host of U.S. Fortune 500 companies and major academic<br />

institutions.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!